Assembly Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Assembly Biosciences

09/11/2022 11:38

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 47 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of 48 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Assembly Biosciences Inc shares had fallen by 16.5% this
quarter and lost 41.2% so far this year.
    * The company reported a quarterly loss of $23.15 million.
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $2.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 11:38 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.47          -0.48          Missed
 Jun. 30 2022      -0.47          -0.51          Missed
 Mar. 31 2022      -0.47          -0.48          Missed
 Dec. 31 2021      -0.48          -0.38          Beat